Feature Channels: Clinical Trials

• share
• favorite_border

La regeneración del músculo esquelético y los síntomas de la incontinencia urinaria por esfuerzo en una investigación preclínica indican una mejora tras el uso de una sustancia acelular descubierta en Mayo Clinic. Los equipos del Dr. en Ciencias Atta Behfar y del Dr. Emanuel Trabuco encabezaron esta investigación en una colaboración entre los Departamentos de Medicina Cardiovascular y de Obstetricia y Ginecología de Mayo Clinic. El artículo se ha publicado en NPJ Regenerative Medicine.

• share
• favorite_border

临床前研究中的再生骨骼肌和压力性尿失禁的症状表明，在使用妙佑医疗国际(Mayo Clinic) 发现的无细胞物质后，症状有所改善。Atta Behfar医学博士/博士和Emanuel Trabuco医学博士的团队在妙佑医疗国际心血管医学部和妇产科之间开展合作，领导了这项研究。这篇论文发表在NPJ Regenerative Medicine上。

• share
• favorite_border

Músculo esquelético regenerado e sintomas de incontinência urinária por esforço em pesquisa pré-clínica sugerem melhora após o uso de uma substância livre de células descoberta na Mayo Clinic. As esquipes do Dr. Atta Behfar, Ph.D. e do Dr. Emanuel Trabuco lideram a pesquisa em uma colaboração entre os Departamentos de Medicina Cardiovascular e de Obstetrícia e Ginecologia da Mayo Clinic. O artigo foi publicado na revista NPJ Regenerative Medicine.

• share
• favorite_border

• share
• favorite_border

Researchers at Washington University School of Medicine in St. Louis have found a biomarker that identifies, with up to 89% accuracy, people with a rare, deadly, untreatable brain disease called corticobasal degeneration (CBD). The biomarker could accelerate efforts to develop treatments for CBD.

• share
• favorite_border

Patients who take statins to lower high cholesterol levels often complain of muscle pains, which can lead them to stop taking the highly effective medication and put them at greater risk of heart attack or stroke.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) announced today that Alexandra Popma, MD, has joined the organization as Executive Director of the CRF Clinical Trials Center.

• share
• favorite_border

UC San Diego Alpha Stem Cell Clinic awarded $8M to expand clinical trials of novel stem cell therapies. The CIRM award will advance partnerships between academic and industry experts in San Diego to expedite clinical trials for patients with difficult-to-treat diseases.

• share
• favorite_border

Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic MRI-Guided On-table Adaptive Radiation Therapy, also known as SMART.

• share
• favorite_border

Experts from the Jona Goldrich Center for Alzheimer’s and Memory Disorders at Cedars-Sinai are available for interviews and to comment on research being presented at the conference.

• share
• favorite_border

PCORI funding will support trial to see if early transition to oral antibiotic therapy from intravenous administration improves outcomes for patients with gram-negative bloodstream infections

• share
• favorite_border

Preclinical study suggests that a class of new drugs already in clinical trials might work especially well in breast cancer patients who have acquired the so-called Y537S mutation signals that their disease has taken an aggressive course and may become resistant to endocrine therapy

• share
• favorite_border

A polymer-based microshunt is safe and effective in pediatric patients with refractory childhood glaucoma, according to a small, single-center case series at the UC Davis Health Eye Center. The children in the study needed trabeculectomy or implantation of a glaucoma drainage device.

• share
• favorite_border

Research finds low-certainty evidence that programs such as emergency rent assistance, legal assistance with waitlist priority for public housing, long-term rent subsidies and homeownership assistance lead to positive health outcomes.

• share
• favorite_border

The recovery of Jesus Torres, a patient at Loyola Medicine with acute myeloid leukemia, highlights the importance of access to innovative, experimental treatments for blood cancers for all communities. As a world-class research institute, Loyola Medicine provides unique, life-saving therapies through its participation in clinical trials, such as a phase 3 clinical trial that uses umbilical cord blood transplantation to treat patients with acute myeloid leukemia.

• share
• favorite_border

AI-based approach could make it easier to incorporate metabolic tumor volume into clinical trials and possibly patient care

• share
• favorite_border

Baylor Scott & White The Heart Hospital, Plano, Texas, changed its treatment paradigm for its COVID-19 patients receiving ECMO during the pandemic, finding that progressive mobility and a more aggressive application of rehabilitation therapies contributed to significantly higher survival rates.

• share
• favorite_border

A scalpel-free, high-tech form of brain surgery pioneered at UVA Health offers long-term relief for patients with essential tremor, a common movement disorder, a five-year review shows.

• share
• favorite_border

Here are some of the latest articles that have been added to the Arthritis channel on Newswise.

• share
• favorite_border

A guided mindfulness-based stress reduction program was as effective as use of the gold-standard drug -- the common antidepressant drug escitalopram -- for patients with anxiety disorders, according to results of a first-of-its-kind, randomized clinical trial led by researchers at Georgetown University Medical Center.

• share
• favorite_border

A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding light on how to more effectively treat atrial fibrillation (AF) – a common heart rhythm problem associated with increased risk of stroke and heart failure.

• share
• favorite_border

estoring blood flow to the legs, whether through bypass surgery or a less invasive artery-opening procedure with a stent, reduced pain and improved quality of life for people with peripheral artery disease (PAD), according to preliminary, late-breaking research presented today at the American Heart Association’s Scientific Sessions 2022.

• share
• favorite_border

Suggests a more proactive, innate immune response among females

• share
• favorite_border

After showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial led by Penn Medicine scientists.

• share
• favorite_border

In clinical trials of patients with chronic kidney disease, combining information from the treatment effects on two markers of kidney disease progression—urinary albumin:creatinine ratio change and glomerular filtration rate slope—improves predictions of treatment effects on clinical endpoints.

• share
• favorite_border

Patients with non-metastatic soft tissue sarcoma (STS) who need pre-operative radiation therapy can safely receive hypofractionated treatment over three weeks instead of five, with comparable tumor control and no increased risk of major complications in wound healing, according to researchers at The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person and online at ASN Kidney Week 2022 November 3–November 6.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.

• share
• favorite_border

A targeted therapy for children with high-risk Hodgkin lymphoma significantly reduced relapse rates, a large multicenter clinical trial conducted by the Children’s Oncology Group shows. The study results have been reported in the New England Journal of Medicine.

• share
• favorite_border

Investigators from Cedars-Sinai Cancer have identified an investigational therapeutic approach that could be effective against treatment-resistant prostate cancer. Results of their Phase II clinical trial, published in the peer-reviewed journal Molecular Therapy, have led to a larger, multicenter trial that will soon be underway.

• share
• favorite_border

A recent analysis indicates that dapagliflozin is a cost-effective treatment in patients with chronic kidney disease in addition to standard of care.

• share
• favorite_border

Drug companies and university-based teams are working urgently to find and test new medications that could prevent or slow the decline of brain function in older adults. But a new study suggests they’ll need to work harder to find volunteers for their clinical trials.

• share
• favorite_border

The American College of Rheumatology (ACR) has released Continuing Medical Education (CME) for dermatologists and nephrologists to help them learn more about clinical trials for lupus patients in their treatment areas and the importance of getting more of African American/Black patients enrolled.

• share
• favorite_border

New research published in the Journal of the American College of Cardiology shows the use of drug-coated balloons is an optimal approach compared to bare metal stents in treating femoropopliteal lesions.

• share
• favorite_border

New study is the first of its kind to focus on Hispanic children, who often have more severe disease. A novel clinical trial at Children’s Hospital Los Angeles is investigating whether butyrate—a short-chain fatty acid typically produced by gut bacteria—can be a potential therapy for children with ulcerative colitis.